Long Beach Research Institute is a clinical research site located in Long Beach, California, United States 90805.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Long Beach Research Institute has participated in 15 clinical trials with 12 currently active.
Therapeutic areas: Diabetes Mellitus, Type 2, Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis.
Sponsors: Eli Lilly and Company, Amgen, Alumis Inc.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Long Beach Research Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Long Beach Research Institute has 15 clinical trials on record, with 12 currently active. Their work covers Diabetes Mellitus, Type 2, Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis.
Yes — Long Beach Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.